經歷

國防部軍醫局藥政管理處上校處長
三軍衛材供應處上校處長
國軍桃園總醫院臨床藥劑科上校主任
三軍衛材供應處上校處長
國軍花蓮總醫院臨床藥劑科上校主任
三軍總醫院衛材補給保養室中校主任、三軍總醫院臨床藥學部總藥師、組長、資深藥師
軍醫局藥政處中校編審
美國華盛頓大學藥學系(UW) 1年進修學者
國防醫學院藥學系系友聯誼會理事長

發表著作

1. Lin TK, Lee MC, Cheng YH, Ma T, Chen MC, Yang TY, Jong GP. The association between SGLT2 inhibitors and new-onset acute coronary syndrome in the elderly: a population-based longitudinal cohort study. Diabetol Metab Syndr. 2023 Aug 17;15(1):170. [SCI IF 4.8]
2. Jong GP, Lin TK, Liao PL, Huang JY, Yang TY, Pan LF. Risk of New-onset Stroke in Patients with Type 2 Diabetes with Chronic Kidney Disease on Sodium-glucose Co-transporter-2 Inhibitor Users. Transl Stroke Res. 2023 Jul 14. [SCI IF 6.829]
3. Lin MH, Wu WT, Chen YC, Lin TK, Chou YC, Sun CA. Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study. Diabetol Metab Syndr. 2023 May 10;15(1):96. [SCI IF 4.8]
4. Chang CM, Chen YC, Wu WT, Lin TK, Chou YC, Lin MH, Sun CA. Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study. Osteoporos Int. 2023 Apr 20. [SCI IF 5.071]
5. Jong GP, Lin TK, Huang JY, Liao PL, Yang TY, Pan LF. Risk of New-Onset Dementia in Patients with Chronic Kidney Disease on Statin Users: A Population-Based Cohort Study. Biomedicines. 2023 Apr 2;11(4):1073. [SCI IF 6.081]
6. Chung MH, Chen YC, Wu WT, Lin MH, Yang YJ, Hueng DY, Lin TK, Chou YC, Sun CA. Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study. Int J Environ Res Public Health. 2022 Nov 21;19(22):15359. [SCI IF 4.5]
7. Lin TK, Chen YH, Huang JY, Liao PL, Chen MC, Pan LF, Jong GP. Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 diabetes: A population-based cohort study. Front Cardiovasc Med. 2022 Aug 9;9:966708. [SCI IF 5.846]
8. Lin TK, Tsai CF, Huang JY, Pan LF, Jong GP. Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study. J Pers Med. 2022 May 19;12(5):824. [SCI IF 4.945]
9. Siao WZ, Lin TK, Huang JY, Tsai CF, Jong GP. The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study. Diab Vasc Dis Res. 2022 May-Jun;19(3) [SCI IF 2.68]
10. Lin TK, Huang JY, Pan LF, Jong GP. Gender- and age-related differences of statin use on incident dementia in patients with rheumatoid arthritis: a Nationwide population-based cohort study. Lipids Health Dis. 2021 Apr 20;20(1):37. [SCI IF 3.876]
11. Chen HY, Su PY, Lin TK, Jong GP. Association between statin use and osteoporotic fracture in patients with chronic obstructive pulmonary disease: a population-based, matched case-control study. Lipids Health Dis. 2020 Nov 3;19(1):232. [SCI IF 3.876]
12. Chang CF, Liou YS, Lin TK, Ma S, Hu YR, Chen HY, Jong GP. High exposure to statins decrease the risk of new-onset dementia: A nationwide population-based longitudinal cohort study. Medicine (Baltimore). 2019 Aug;98(34). [SCI IF 1.552]
13. Lin TK, Chou P, Lin CH, Hung YJ, Jong GP. Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study. PLoS One. 2018 May 3;13(5) [SCI IF 2.806]
14. Lin TK, Liou YS, Lin CH, Chou P, Jong GP. High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study. Clin Epidemiol. 2018 Jan 18;10:159-165. [SCI IF 7.056]